JAPANESE FOUNDATION FOR CANCER RESEARCH
Patent Owner
Stats
- 15 US PATENTS IN FORCE
- 7 US APPLICATIONS PENDING
- Jan 04, 2018 most recent publication
Details
- 15 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 448 Total Citation Count
- Feb 03, 1983 Earliest Filing
- 25 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0258,940 MULTIFUNCTIONAL METAL NANOSTRUCTURE AND METHOD FOR PRODUCING SAMEOct 17, 14Sep 08, 16[A61K, G01N]
2016/0002,699 METHOD FOR SCREENING FOOD INGREDIENTS AND FOOD COMPOSITIONSFeb 10, 14Jan 07, 16[C12Q, G01N]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9798770 Information processing unit, information processing method, and programDec 06, 13Oct 24, 17[G06Q, G06T, G06F, G06K]
9135703 Information processing apparatus and information processing method and program for themSep 29, 11Sep 15, 15[G06T, A61B, G06K]
9110305 Microscope cell staining observation system, method, and computer program productNov 19, 10Aug 18, 15[H04N, G01N, G02B]
9105239 Image processing device, image processing method, recording medium, and programMay 22, 12Aug 11, 15[G09G]
8937653 Microscope system, specimen observing method, and computer-readable recording mediumAug 09, 11Jan 20, 15[H04N, G02B]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0185,223 Compositions Comprising RAC Mutants, and Methods of Use ThereofAbandonedJul 26, 13Jul 02, 15[A61K, C12Q, C12N, G01N, C07K]
2015/0110,882 MULTIFUNCTIONAL METALLIC NANOSTRUCTURE AND METHOD FOR MANUFACTURING THE SAMEAbandonedOct 18, 13Apr 23, 15[A61K, G01N]
2010/0322,502 MEDICAL DIAGNOSIS SUPPORT DEVICE, IMAGE PROCESSING METHOD, IMAGE PROCESSING PROGRAM, AND VIRTUAL MICROSCOPE SYSTEMAbandonedJun 16, 10Dec 23, 10[G06K]
2010/0291,242 ANTAGONIST AGAINST TOLERANCE TO ANTICANCER DRUGSAbandonedDec 28, 09Nov 18, 10[A61K, A61P]
2010/0272,334 Microscope System, Specimen Observation Method, and Computer Program ProductAbandonedJun 17, 10Oct 28, 10[G06T]
2010/0141,752 Microscope System, Specimen Observing Method, and Computer Program ProductAbandonedDec 02, 09Jun 10, 10[H04N, G09G]
2009/0202,569 Prophylactic/Therapeutic Agent for CancerAbandonedApr 06, 07Aug 13, 09[A61K, C07H, C12N, C07K]
2009/0155,241 Prophylactic/therapeutic agent for cancerAbandonedJul 22, 05Jun 18, 09[A61K, C07H, C12Q, C12N, C07C, G01N, C07K]
2008/0249,036 Antagonist Against Tolerance to Anticancer DrugsAbandonedAug 31, 05Oct 09, 08[A61K, C12Q, C12N, A61P, C07J]
2007/0238,098 Method and Kit for Predicting Adverse Side Effects of Paclitaxel TherapyAbandonedNov 05, 04Oct 11, 07[C12Q]
2004/0236,742 Clustering apparatus, clustering method, and clustering programAbandonedMar 05, 04Nov 25, 04[G06F]
5620868 Gene coded for interleukin-2 polypeptide, recombinant DNA carrying the said gene, a living cell line possessing the recombinant DNA, and method for producing interleukin-2 using the said cellExpiredDec 26, 91Apr 15, 97[C12P, C12N]
5216172 1,4-dihydropyridine-4-aryl-2,6-dimethyl-3,5-dicarboxylates useful as agents against drug resistant tumor cellsExpiredJan 28, 91Jun 01, 93[A61K, C07D]
5087560 Monoclonal antibody for use in drug resistant cancers and production thereofExpiredOct 01, 90Feb 11, 92[C12P, C12N, C12G]
4923871 Certain 2,6-dimethyl-4-(pyrazolo[1,5a]-pyridin-3-yl)1,4-dihydro-pyridine-3,5-dicarboxylate derivatives and compositions containing sameExpiredNov 25, 87May 08, 90[A61K, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.